Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Enfold Institute Founders Comment on Mount Sinai-Columbia 5-MeO-DMT Research


News provided by

Enfold

May 29, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Enfold co-founders Steve Rio and Austin Austin. Photo by Juno Kim.
Enfold co-founders Steve Rio and Austin Austin. Photo by Juno Kim.

Why the psychedelic trip is crucial for transformation

VANCOUVER, BC, May 29, 2024 /PRNewswire-PRWeb/ -- In light of recent groundbreaking research from Mount Sinai Hospital and Columbia University on the potential of 5-MeO-DMT in treating depression and anxiety, Enfold co-founders Steve Rio and Austin Austin emphasize the crucial role of the psychedelic experience in the healing process. The study, published in the journal Nature, found that a modified analog of 5-MeO-DMT, a compound found in the toxin of the Colorado River toad, reduced symptoms of depression and anxiety in mice without inducing hallucinogenic effects.

While the research represents a significant step forward in understanding the therapeutic potential of psychedelic compounds, Rio and Austin caution against oversimplifying the complexities of the psychedelic experience by reducing treatment to individual receptors.

The human connection experienced before, during, and after the psychedelic journey is critical to the transformations that our guests experience.

Post this

"The ongoing research on 5-MeO-DMT is incredibly promising," says Rio, "but it's highly reductive to think that depression can be solved without a psychological and experiential component. Experiencing and surrendering to the psychedelic journey is a crucial aspect of the healing process. The human connection experienced before, during, and after the psychedelic journey is critical to the transformations that our guests experience."

Enfold, a pioneering psychedelic institute in British Columbia, Canada, has been quietly developing the most comprehensive protocol for 5-MeO-DMT in the world since its founding in 2019. Enfold's innovative protocol combines the powerful psychedelic compound 5-MeO-DMT with a carefully curated blend of body-centered therapies, personalized guidance, and wisdom teachings to facilitate profound physical, psychological, and spiritual healing. Enfold's intensives have been consistently sold out for the past five years, with participants traveling from Asia, Europe, and North America to experience their transformative programs.

"At Enfold, we've witnessed firsthand the profound impact of the psychedelic experience on our participants," says Austin. "Our comprehensive protocol goes beyond just the administration of 5-MeO-DMT; we create a safe, supportive environment that allows individuals to fully surrender to the experience and integrate the insights gained into their daily lives."

Sande Higgins, an Enfold guest, says: "As a retired RCMP officer and plane crash survivor, I've struggled with PTSD and survivor's guilt for years. During my 5-MeO-DMT experience with Enfold, I confronted my trauma head-on. The weight of the guilt and grief I'd been carrying for so long finally lifted. I saw my experience from a higher perspective—not as a punishment, but as a difficult yet transformative chapter in my story. This would not have been possible without the set, setting, and ongoing support that Enfold provided."

Enfold completed a seed funding round in 2022, positioning them to expand their offerings and further advance their mission of providing transformative experiences and spiritual guidance through the use of powerful, legal psychedelic medicines. Enfold has also partnered with the University Health Network Psychedelic Psychotherapy Research Group (UHN PPRG) and the Centre for Addiction and Mental Health (CAMH) to study the impact of 5-MeO-DMT when combined with somatic and psychospiritual therapeutic modalities in a relational, multi-day format.

"We believe that the future of mental health treatment lies in a holistic approach that acknowledges the importance of the psychedelic experience," says Rio. "As scientists continue to explore the therapeutic potential of compounds like 5-MeO-DMT, it's crucial that we don't lose sight of the transformative power of the journey itself."

About Enfold

Enfold is a pioneering psychedelic institute located just outside of Vancouver in the stunning Howe Sound region of British Columbia, Canada. Founded in 2019 by husband and wife team, Steve Rio and Austin Austin, Enfold offers transformative experiences and spiritual guidance through the use of powerful, legal psychedelic medicines, with a particular focus on 5-MeO-DMT. The Institute's unique psychospiritual model integrates work with the nervous system, personality system, and spiritual system to provide a holistic approach to healing and personal growth.

Media Contact

Brad Burge, Enfold, 1 6508636887, brad@integrationcommunications.com, https://enfold.org

SOURCE Enfold

Modal title

Steve and Austin, Enfold's co-founders. Photo by Juno Kim.
Steve and Austin, Enfold's co-founders. Photo by Juno Kim.
Enfold offers safe, guided, 5-MeO-DMT retreat experiences in British Columbia.
Enfold offers safe, guided, 5-MeO-DMT retreat experiences in British Columbia.
Steve and Austin, Enfold's co-founders. Photo by Juno Kim. Enfold offers safe, guided, 5-MeO-DMT retreat experiences in British Columbia.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.